title: Positron emission tomography for lymphoma staging: tissue remains the issue.
authors.forename: Ramaprasad
authors.initials: R
authors.lastname: Srinivasan
authors.forename: Armando
authors.initials: A
authors.lastname: Filie
authors.forename: James
authors.initials: J
authors.lastname: Reynolds
authors.forename: Richard
authors.initials: R
authors.lastname: Chang
authors.forename: Catherine
authors.initials: C
authors.lastname: Chow
authors.forename: David S
authors.initials: DS
authors.lastname: Schrump
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Takahashi
authors.forename: Anthony F
authors.initials: AF
authors.lastname: Suffredini
authors.forename: Richard W
authors.initials: RW
authors.lastname: Childs
mesh_terms: D000293:Adolescent; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016393:Lymphoma, B-Cell / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology*; D008228:Lymphoma, Non-Hodgkin / Q000000981:diagnostic imaging* / Q000188:drug therapy / Q000473:pathology*; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed